Literature DB >> 10783152

Discoidin domain receptor 1 (DDR1) signaling in PC12 cells: activation of juxtamembrane domains in PDGFR/DDR/TrkA chimeric receptors.

E D Foehr1, A Tatavos, E Tanabe, S Raffioni, S Goetz, E Dimarco, M De Luca, R A Bradshaw.   

Abstract

The discoidin domain receptor (DDR1) is characterized by a discoidin I motif in the extracellular domain, an unusually long cytoplasmic juxtamembrane (JM) region, and a kinase domain that is 45% identical to that of the NGF receptor, TrkA. DDR1 also has a major splice form, which has a 37 amino acid insert in the JM region with a consensus Shc PTB site that is lacking in the shorter receptor. One class of ligands for the DDR receptors has recently been identified as being derived from the collagen family, but neither native PC12 cells, which express modest amounts of DDR1, nor transfected PC12 cells, which express much larger amounts of DDR1, respond to this ligand. A chimeric receptor, containing the extracellular domain of hPDGFRbeta fused to the transmembrane and intracellular regions of DDR1, also fails to mediate neuronal-like differentiation in stably transfected PC12 cells and is only weakly autophosphorylated. However, chimeric receptors, which are composed of combinations of intracellular regions from DDR1 and TrkA (with the extracellular domain of hPDGFRbeta), in some cases provided ligand (PDGF) -inducible receptor responses. Those with the TrkA kinase domain and the DDR1 JM regions were able to produce differentiation to varying degrees, whereas the opposite combination did not. Analysis of the signaling responses of the two chimeras with DDR1 JM sequences (with and without the insert) indicated that the shorter sequence bound and activated FRS2 whereas the insert-containing form activated Shc instead. Both activated PLCgamma through the carboxyl-terminal tyrosine of the TrkA domain (Y785 in TrkA residue numbering). Mutation of this site (Y-->F) eliminated PLCgamma activation (indicating there are no other cryptic binding sites for PLCgamma in the DDR1 sequences) and markedly reduced the differentiative activity of the receptor. This is in contrast to TrkA (or PDGFRbeta/TrkA chimeras), where ablation of this pathway has no notable effect on PC12 cell morphogenic responses. Thus, the activation of FRS2 and Shc (leading to MAPK activation) is weaker in the DDR1/TrkA chimeras than in TrkA alone, and the PLCgamma contribution becomes essential for full response. Nonetheless, both DDR1 JM regions contain potentially usable signaling sites, albeit they apparently are not activated directly in DDR1 (or DDR1 chimeras) in a ligand-dependent fashion. These findings suggest that the DDR1 receptors do have signaling capacity but may require additional components or altered conditions to fully activate their kinase domains and/or sustain the activation of the JM sites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783152     DOI: 10.1096/fasebj.14.7.973

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  13 in total

Review 1.  Discoidin domain receptors: Micro insights into macro assemblies.

Authors:  Gunjan Agarwal; Adam W Smith; Blain Jones
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-06-21       Impact factor: 4.739

Review 2.  PDGF: the nuts and bolts of signalling toolbox.

Authors:  Ammad Ahmad Farooqi; Salman Waseem; Asma M Riaz; Bilal Ahmed Dilawar; Shahzeray Mukhtar; Sehrish Minhaj; Makhdoom Saad Waseem; Suneel Daniel; Beenish Ali Malik; Ali Nawaz; Shahzad Bhatti
Journal:  Tumour Biol       Date:  2011-07-19

Review 3.  Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling.

Authors:  Hsueh-Liang Fu; Rajeshwari R Valiathan; Richard Arkwright; Anjum Sohail; Cosmin Mihai; Malika Kumarasiri; Kiran V Mahasenan; Shahriar Mobashery; Paul Huang; Gunjan Agarwal; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-01-18       Impact factor: 5.157

Review 4.  Discoidin domain receptor 1: a new class of receptor regulating leukocyte-collagen interaction.

Authors:  Teizo Yoshimura; Wataru Matsuyama; Hidenobu Kamohara
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Discoidin domain receptor 1: isoform expression and potential functions in cirrhotic human liver.

Authors:  Sunmi Song; Nicholas A Shackel; Xin M Wang; Katerina Ajami; Geoffrey W McCaughan; Mark D Gorrell
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

6.  Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2.

Authors:  Rosalyn Ram; Gustavo Lorente; Karoly Nikolich; Roman Urfer; Erik Foehr; Usha Nagavarapu
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

7.  Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development.

Authors:  W F Vogel; A Aszódi; F Alves; T Pawson
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

8.  A discoidin domain receptor 1 knock-out mouse as a novel model for osteoarthritis of the temporomandibular joint.

Authors:  Boris Schminke; Hayat Muhammad; Christa Bode; Boguslawa Sadowski; Regina Gerter; Nikolaus Gersdorff; Ralf Bürgers; Efrat Monsonego-Ornan; Vicki Rosen; Nicolai Miosge
Journal:  Cell Mol Life Sci       Date:  2013-08-04       Impact factor: 9.261

9.  High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia.

Authors:  Marc M Loriaux; Ross L Levine; Jeffrey W Tyner; Stefan Fröhling; Claudia Scholl; Eric P Stoffregen; Gerlinde Wernig; Heidi Erickson; Christopher A Eide; Roland Berger; Olivier A Bernard; James D Griffin; Richard M Stone; Benjamin Lee; Matthew Meyerson; Michael C Heinrich; Michael W Deininger; D Gary Gilliland; Brian J Druker
Journal:  Blood       Date:  2008-02-05       Impact factor: 22.113

10.  Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.

Authors:  Hyung-Gu Kim; Li Tan; Ellen L Weisberg; Feiyang Liu; Peter Canning; Hwan Geun Choi; Scott A Ezell; Hong Wu; Zheng Zhao; Jinhua Wang; Anna Mandinova; James D Griffin; Alex N Bullock; Qingsong Liu; Sam W Lee; Nathanael S Gray
Journal:  ACS Chem Biol       Date:  2013-08-13       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.